CAS 866405-64-3 appears in our catalog under these names: Dorsomorphin/ 99.48% (existing batch purity), Dorsomorphin (Compound C), Dorsomorphin, Dorsomorphin, >97.0%(HPLC), 6-[4-(2-Piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine, 98.00%. Offered by: TargetMol, GLPBio, Biosynth, TCI, Chemat. Available pack sizes: 5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 10mM (in 1ml dmso), 5g.
Dorsomorphin is a pyrazolopyrimidine that is pyrazolo[1,5-a]pyrimidine which is substituted at positions 3 and 6 by pyridin-4-yl and p-[2-(piperidin-1-yl)ethoxy]phenyl groups, respectively. It is a potent, selective, reversible, and ATP-competitive inhibitor of AMPK (AMP-activated protein kinase, EC 2.7.11.31) and a selective inhibitor of bone morphogenetic protein (BMP) signaling. It has a role as an EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor and a bone morphogenetic protein receptor antagonist. It is a member of piperidines, a member of pyridines, an aromatic ether and a pyrazolopyrimidine.
Source: ChEBI
| Molecular formula | C24H25N5O |
|---|---|
| Molecular weight | 399.5 g/mol |
| IUPAC name | 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine |
| InChIKey | XHBVYDAKJHETMP-UHFFFAOYSA-N |
| SMILES | C1CCN(CC1)CCOC2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC=C5)N=C3 |
Computed by PubChem (NCBI)